NIH Launches Mammoth Effort to Understand and Treat Long COVID
The big National Institutes of Health (NIH) effort on long COVID is rolling. It hasn't come easily or quickly and the NIH has a lot of catching up to do. The world has known long COVID is a serious problem since last summer, but you wouldn't have known it by the NIH....
“Emerging Options for Autoimmune ME/CFS”: Scheibenbogen at the 2021 IACFS/ME Conference
This is the second in a series of blogs on the virtual 2021 International IACFS/ME Conference, “A Huge Problem and Major Crisis”: Avindra Nath on Long COVID at the IACFS/ME 2021 Conference Dr. Scheibenbogen shows the impact that a leader in the field can have....
Fatigue Goes Legit at the NIH: The “Beyond the Symptom – Biology of Fatigue” Workshop
Although fatigue has traditionally been scorned in medical research. studies show that ME/CFS - the "chronic fatigue syndrome" - is significantly more functionally disabling than multiple sclerosis, heart failure, diabetes, depression, and others. ME/CFS may be the...
Mitochondrial Enhancers for ME/CFS and Fibromyalgia Pt IV: N-Acetyl Cysteine (NAC)
In the 4th part of a series focusing on Mitochondrial Enhancers for ME/CFS and Fibromyalgia we turn to a surprising supplement - N-acetyl-cysteine (NAC). You don't often hear of NAC as a mitochondrial supplement. Lee Know's book "Mitochondria and the Future of...
Does Low Dose Naltrexone Improve Natural Killer Cell Functioning in ME/CFS?
Naltrexone is mostly used to help people addicted to opioid drugs safely withdraw from them, but LDN is used for a far different purpose. By temporarily blocking opioid receptors, LDN, in effect, unleashes them – causing a rebound effect and an increase in the...
The Cortene Drug Trial Results for ME/CFS Are In
Cortene's appearance in the chronic fatigue syndrome (ME/CFS) world a couple of years ago was like a breath of fresh air. The small drug company wanted to do something unusual in the annals of this neglected disease - run a clinical trial - and not with a drug anyone...
Good Drug, Bad Company? Leronlimab, long COVID, and Bruce Patterson’s Attempt to Takeover CytoDyn
Bruce Patterson MD had made a lot of news with his assertion that very high levels of a chemokine called CCL5/RANTES were directing immune cells to go on the attack in long COVID. Patterson's first study suggested that a weak adaptive immune response to the virus was...
Is FibroCOVID a Real Thing? Plus Small Fiber Neuropathy Found in Long COVID
Both chronic fatigue syndrome (ME/CFS) and postural orthostatic tachycardia syndrome (POTS) have received far more attention than fibromyalgia regarding long COVID. Despite the large overlap between fibromyalgia (FM) and ME/CFS, and the fact that FM can be triggered...
“A Huge Problem and Major Crisis”: Avindra Nath on Long COVID at the IACFS/ME 2021 Conference
"We have a huge problem and a major crisis on our hands." Avindra Nath - on long COVID - at the conference "I think the tools we've applied to study ME/CFS can now easily be applied to long COVID as well. And vice versa. What we've learned on long COVID is...
